|4Aug 30, 6:06 PM ET

Kuipers Peter J. 4

4 · OMNICELL, INC. · Filed Aug 30, 2022

Insider Transaction Report

Form 4
Period: 2022-08-26
Kuipers Peter J.
Executive V.P. CFO
Transactions
  • Sale

    Common Stock

    2022-08-26$108.29/sh15,481$1,676,45861,326 total
  • Exercise/Conversion

    Stock Option NQ (Right to Buy)

    2022-08-2611,46017,248 total
    Exercise: $78.91From: 2020-02-13Exp: 2029-02-12Common Stock (11,460 underlying)
  • Exercise/Conversion

    Common Stock

    2022-08-26$44.25/sh+4,040$178,77065,366 total
  • Sale

    Common Stock

    2022-08-26$108.74/sh19$2,06676,807 total
  • Exercise/Conversion

    Common Stock

    2022-08-26$78.91/sh+11,460$904,30976,826 total
  • Exercise/Conversion

    Stock Option NQ (Right to Buy)

    2022-08-264,0400 total
    Exercise: $44.25From: 2019-02-06Exp: 2028-02-05Common Stock (4,040 underlying)
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price of $108.2913. The sold price range between $107.72 to $108.6550. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    form4-08302022_030833.xmlPrimary